Effect of Talactoferrin in Adults With Non-Small Cell Lung Cancer

NCT00923741 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

NIH

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: Talactoferrin
PROCEDURE: Apheresis

Sponsor

National Cancer Institute (NCI)